ENTITY
iX Biopharma

iX Biopharma (IXBIO SP)

5
Analysis
Health Care • Singapore
iX Biopharma is a specialty pharmaceutical and nutraceutical company that develops and commercializes innovative therapies for pain and other health conditions, leveraging proprietary sublingual drug delivery technologies such as WaferiX and WaferlogiX. Key products in development include Wafermine (ketamine wafer) for pain and BnoX (buprenorphine). The company was founded in Singapore in 2008.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x